These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36771254)

  • 1. Magnesium Administration in Chronic Kidney Disease.
    Vermeulen EA; Vervloet MG
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.
    Vermeulen EA; Eelderink C; Hoekstra T; van Ballegooijen AJ; Raijmakers P; Beulens JW; de Borst MH; Vervloet MG
    Trials; 2022 Sep; 23(1):769. PubMed ID: 36096824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium and cardiovascular complications of chronic kidney disease.
    Massy ZA; Drüeke TB
    Nat Rev Nephrol; 2015 Jul; 11(7):432-42. PubMed ID: 25963594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.
    Bressendorff I; Hansen D; Schou M; Kragelund C; Brandi L
    BMJ Open; 2017 Jun; 7(6):e016795. PubMed ID: 28645983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease.
    Hutcheson JD; Goettsch C
    Circ Res; 2023 Apr; 132(8):993-1012. PubMed ID: 37053279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
    Xiong J; He T; Wang M; Nie L; Zhang Y; Wang Y; Huang Y; Feng B; Zhang J; Zhao J
    J Nephrol; 2019 Oct; 32(5):791-802. PubMed ID: 30888644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of magnesium in CKD.
    Sakaguchi Y
    Clin Exp Nephrol; 2022 May; 26(5):379-384. PubMed ID: 35076791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Omata M; Fukagawa M; Kakuta T
    Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium to prevent kidney disease-associated vascular calcification: crystal clear?
    Ter Braake AD; Vervloet MG; de Baaij JHF; Hoenderop JGJ
    Nephrol Dial Transplant; 2022 Feb; 37(3):421-429. PubMed ID: 33374019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium and Progression of Chronic Kidney Disease: Benefits Beyond Cardiovascular Protection?
    Sakaguchi Y; Hamano T; Isaka Y
    Adv Chronic Kidney Dis; 2018 May; 25(3):274-280. PubMed ID: 29793667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineral metabolism and cardiovascular disease in CKD.
    Fujii H; Joki N
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnesium disorder and its clinical significance in chronic kidney disease].
    Okuno S
    Clin Calcium; 2012 Aug; 22(8):1243-9. PubMed ID: 22846361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.
    Sakaguchi Y; Hamano T; Isaka Y
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28178182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease.
    Khouzam N; Wesseling-Perry K
    Pediatr Nephrol; 2019 Jan; 34(1):1-10. PubMed ID: 28939921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease.
    Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S
    Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium in CKD: more than a calcification inhibitor?
    Floege J
    J Nephrol; 2015 Jun; 28(3):269-77. PubMed ID: 25227765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival.
    Massy ZA; Drüeke TB
    Clin Kidney J; 2012 Feb; 5(Suppl 1):i52-i61. PubMed ID: 26069821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.